» Articles » PMID: 37671566

Pleiotropy with Sex-specific Traits Reveals Genetic Aspects of Sex Differences in Parkinson's Disease

Abstract

Parkinson's disease is an age-related neurodegenerative disorder with a higher incidence in males than females. The causes for this sex difference are unknown. Genome-wide association studies (GWAS) have identified 90 Parkinson's disease risk loci, but the genetic studies have not found sex-specific differences in allele frequency on autosomal chromosomes or sex chromosomes. Genetic variants, however, could exert sex-specific effects on gene function and regulation of gene expression. To identify genetic loci that might have sex-specific effects, we studied pleiotropy between Parkinson's disease and sex-specific traits. Summary statistics from GWASs were acquired from large-scale consortia for Parkinson's disease (n cases = 13 708; n controls = 95 282), age at menarche (n = 368 888 females) and age at menopause (n = 69 360 females). We applied the conditional/conjunctional false discovery rate (FDR) method to identify shared loci between Parkinson's disease and these sex-specific traits. Next, we investigated sex-specific gene expression differences in the superior frontal cortex of both neuropathologically healthy individuals and Parkinson's disease patients (n cases = 61; n controls = 23). To provide biological insights to the genetic pleiotropy, we performed sex-specific expression quantitative trait locus (eQTL) analysis and sex-specific age-related differential expression analysis for genes mapped to Parkinson's disease risk loci. Through conditional/conjunctional FDR analysis we found 11 loci shared between Parkinson's disease and the sex-specific traits age at menarche and age at menopause. Gene-set and pathway analysis of the genes mapped to these loci highlighted the importance of the immune response in determining an increased disease incidence in the male population. Moreover, we highlighted a total of nine genes whose expression or age-related expression in the human brain is influenced by genetic variants in a sex-specific manner. With these analyses we demonstrated that the lack of clear sex-specific differences in allele frequencies for Parkinson's disease loci does not exclude a genetic contribution to differences in disease incidence. Moreover, further studies are needed to elucidate the role that the candidate genes identified here could have in determining a higher incidence of Parkinson's disease in the male population.

Citing Articles

Sex and gender differences in the molecular etiology of Parkinson's disease: considerations for study design and data analysis.

Schaffner S, Tosefsky K, Inskter A, Appel-Cresswell S, Schulze-Hentrich J Biol Sex Differ. 2025; 16(1):7.

PMID: 39901234 PMC: 11789417. DOI: 10.1186/s13293-025-00692-w.


LRRK2-Associated Parkinsonism With and Without Evidence of Alpha-Synuclein Aggregates.

Chahine L, Lafontant D, Choi S, Iwaki H, Blauwendraat C, Singleton A medRxiv. 2024; .

PMID: 39108519 PMC: 11302724. DOI: 10.1101/2024.07.22.24310806.


Copper release by MOF-74(Cu): a novel pharmacological alternative to diseases with deficiency of a vital oligoelement.

Aguila-Rosas J, Garcia-Martinez B, Rios C, Diaz-Ruiz A, Obeso J, Quirino-Barreda C RSC Adv. 2024; 14(2):855-862.

PMID: 38174271 PMC: 10759266. DOI: 10.1039/d3ra07109j.

References
1.
Zhu Z, Zhang F, Hu H, Bakshi A, Robinson M, Powell J . Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016; 48(5):481-7. DOI: 10.1038/ng.3538. View

2.
Piccoli G, Onofri F, Cirnaru M, Kaiser C, Jagtap P, Kastenmuller A . Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain. Mol Cell Biol. 2014; 34(12):2147-61. PMC: 4054300. DOI: 10.1128/MCB.00914-13. View

3.
Quesada A, Lee B, Micevych P . PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol. 2008; 68(5):632-44. PMC: 2667142. DOI: 10.1002/dneu.20609. View

4.
Zhu Y, Yang G, Ahlemeyer B, Pang L, Che X, Culmsee C . Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci. 2002; 22(10):3898-909. PMC: 6757635. DOI: 20026373. View

5.
Al Sweidi S, Sanchez M, Bourque M, Morissette M, Dluzen D, Di Paolo T . Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease. J Neuroendocrinol. 2011; 24(1):48-61. DOI: 10.1111/j.1365-2826.2011.02193.x. View